JP2015007136A5 - - Google Patents

Download PDF

Info

Publication number
JP2015007136A5
JP2015007136A5 JP2014209682A JP2014209682A JP2015007136A5 JP 2015007136 A5 JP2015007136 A5 JP 2015007136A5 JP 2014209682 A JP2014209682 A JP 2014209682A JP 2014209682 A JP2014209682 A JP 2014209682A JP 2015007136 A5 JP2015007136 A5 JP 2015007136A5
Authority
JP
Japan
Prior art keywords
composition
cetirizine
formulation
ophthalmic
concentration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014209682A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015007136A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2015007136A publication Critical patent/JP2015007136A/ja
Publication of JP2015007136A5 publication Critical patent/JP2015007136A5/ja
Pending legal-status Critical Current

Links

JP2014209682A 2009-03-17 2014-10-14 セチリジンの眼科用製剤および使用方法 Pending JP2015007136A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US16100609P 2009-03-17 2009-03-17
US61/161,006 2009-03-17
US17485009P 2009-05-01 2009-05-01
US61/174,850 2009-05-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2012500851A Division JP6033677B2 (ja) 2009-03-17 2010-03-15 セチリジンの眼科用製剤および使用方法

Publications (2)

Publication Number Publication Date
JP2015007136A JP2015007136A (ja) 2015-01-15
JP2015007136A5 true JP2015007136A5 (enExample) 2015-07-02

Family

ID=42738180

Family Applications (8)

Application Number Title Priority Date Filing Date
JP2012500851A Active JP6033677B2 (ja) 2009-03-17 2010-03-15 セチリジンの眼科用製剤および使用方法
JP2014209682A Pending JP2015007136A (ja) 2009-03-17 2014-10-14 セチリジンの眼科用製剤および使用方法
JP2016158650A Active JP6144393B2 (ja) 2009-03-17 2016-08-12 セチリジンの眼科用製剤および使用方法
JP2016158651A Active JP6449202B2 (ja) 2009-03-17 2016-08-12 セチリジンの眼科用製剤および使用方法
JP2018118671A Withdrawn JP2018141022A (ja) 2009-03-17 2018-06-22 セチリジンの眼科用製剤および使用方法
JP2020084425A Active JP7088980B2 (ja) 2009-03-17 2020-05-13 セチリジンの眼科用製剤および使用方法
JP2020084424A Active JP6893573B2 (ja) 2009-03-17 2020-05-13 セチリジンの眼科用製剤および使用方法
JP2021099424A Withdrawn JP2021138760A (ja) 2009-03-17 2021-06-15 セチリジンの眼科用製剤および使用方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2012500851A Active JP6033677B2 (ja) 2009-03-17 2010-03-15 セチリジンの眼科用製剤および使用方法

Family Applications After (6)

Application Number Title Priority Date Filing Date
JP2016158650A Active JP6144393B2 (ja) 2009-03-17 2016-08-12 セチリジンの眼科用製剤および使用方法
JP2016158651A Active JP6449202B2 (ja) 2009-03-17 2016-08-12 セチリジンの眼科用製剤および使用方法
JP2018118671A Withdrawn JP2018141022A (ja) 2009-03-17 2018-06-22 セチリジンの眼科用製剤および使用方法
JP2020084425A Active JP7088980B2 (ja) 2009-03-17 2020-05-13 セチリジンの眼科用製剤および使用方法
JP2020084424A Active JP6893573B2 (ja) 2009-03-17 2020-05-13 セチリジンの眼科用製剤および使用方法
JP2021099424A Withdrawn JP2021138760A (ja) 2009-03-17 2021-06-15 セチリジンの眼科用製剤および使用方法

Country Status (8)

Country Link
US (8) US9254286B2 (enExample)
EP (2) EP3943069B1 (enExample)
JP (8) JP6033677B2 (enExample)
CA (1) CA2755679C (enExample)
ES (2) ES3014823T3 (enExample)
MX (1) MX2011009802A (enExample)
PT (2) PT2408453T (enExample)
WO (1) WO2010107689A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8569273B2 (en) * 2009-03-17 2013-10-29 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
CA2755679C (en) * 2009-03-17 2017-09-12 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use
CA2764473A1 (en) * 2009-06-05 2010-12-09 Aciex Therapeutics, Inc. Ophthalmic formulations of fluticasone and methods of use
US10156386B2 (en) 2010-05-12 2018-12-18 Brooks Automation, Inc. System and method for cryogenic cooling
US20120225918A1 (en) * 2011-03-03 2012-09-06 Voom, Llc Compositions and Methods for Non-Surgical Treatment of Ptosis
TWI544922B (zh) 2011-05-19 2016-08-11 愛爾康研究有限公司 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
CN107880091B (zh) 2012-05-08 2020-12-18 尼科斯眼药公司 疏水性治疗剂的制剂、其制备方法及应用
US8765725B2 (en) 2012-05-08 2014-07-01 Aciex Therapeutics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
US9815865B2 (en) 2013-01-07 2017-11-14 Nicox Ophthalmics, Inc. Preparations of hydrophobic therapeutic agents, methods of manufacture and use thereof
WO2018147409A1 (ja) * 2017-02-13 2018-08-16 日東メディック株式会社 水性点眼点鼻用組成物
AU2018279074B2 (en) * 2017-06-08 2023-12-14 Eye Therapies, Llc Low-dose brimonidine combinations and uses thereof
EP3740193A4 (en) * 2018-01-15 2022-03-02 Seattle Gummy Company SEMI-SOLID ANTHIHISTAMINE COMPOSITIONS AND PROCESSES FOR THE PREPARATION AND USE THEREOF
CN113712908A (zh) * 2020-05-25 2021-11-30 南京帝昌医药科技有限公司 一种用于治疗过敏性结膜炎的组合物其制备方法

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US610373A (en) 1898-09-06 Michele signorastbi
US440779A (en) 1890-11-18 Edward smith axd frederick smith
US518882A (en) 1894-04-24 Mary p
US452535A (en) 1891-05-19 Ehregott theodore winkler
US569855A (en) 1896-10-20 Alvor butterfield
US541989A (en) 1895-07-02 Joseph h
US643692A (en) 1899-09-27 1900-02-20 Bernard H Speckbauch Printing-press.
US682794A (en) 1899-12-19 1901-09-17 Friedrich August Gasch Process of obtaining zinc solutions free from iron and manganese compounds.
US664960A (en) 1900-09-05 1901-01-01 John A Hill Oil-separator and automatic regulating-valve for refrigerating systems.
FI75816C (fi) * 1981-02-06 1988-08-08 Ucb Sa Foerfarande foer framstaellning av terapeutiskt aktiv 2-/4-(difenylmetyl)-1-piperazinyl/-aettiksyror eller dess amid.
US4407791A (en) 1981-09-28 1983-10-04 Alcon Laboratories, Inc. Ophthalmic solutions
US5188826A (en) 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
AU636685B2 (en) 1989-12-18 1993-05-06 Alcon Laboratories, Inc. Compositions of antiallergics and antihistamines and methods for their use
JPH08501561A (ja) 1992-09-24 1996-02-20 セプラコア，インコーポレイテッド （−）セチリジンを用いたアレルギー疾患の治療のための組成物
TW401300B (en) * 1992-12-25 2000-08-11 Senju Pharma Co Antiallergic composition for ophthalmic or nasal use
JPH11511758A (ja) 1996-06-04 1999-10-12 ザ、プロクター、エンド、ギャンブル、カンパニー 鼻腔用ステロイドと抗ヒスタミン剤を含む鼻腔内噴霧薬
SK20099A3 (en) 1996-08-16 2000-08-14 Schering Corp Treatment of upper airway allergic responses with a combination of histamine receptor antagonists
EP0903151A1 (en) 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
US6103735A (en) 1998-10-09 2000-08-15 Schering Corporation Composition and method for treating allergic diseases
US6649602B1 (en) 1999-11-18 2003-11-18 Alcon, Inc. Use of an H1 antagonist and a safe steroid to treat eye conditions
DE10007203A1 (de) 2000-02-17 2001-08-23 Asta Medica Ag Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis
JP2002025272A (ja) 2000-07-10 2002-01-25 Sharp Corp 半導体記憶装置およびその評価方法
AR035509A1 (es) 2000-12-21 2004-06-02 Alcon Inc Solucion de lagrimas artificiales mejorada que contiene una combinacion de tres emolientes y el uso de dicha solucion para la fabricacion de un medicamento
US7243343B2 (en) 2001-04-10 2007-07-10 International Business Machines Corporation Method, compiler and platform independent framework for parsing and generating data structures
US6985573B2 (en) 2001-04-13 2006-01-10 General Instrument Corporation Customer premises equipment that can support multiple call control languages or multiple call agents
US6592896B2 (en) 2001-08-06 2003-07-15 The Quigley Corporation Medicinal composition and method of using it
US6827946B2 (en) 2001-12-05 2004-12-07 Collegium Pharmaceutical, Inc. Compositions containing both sedative and non-sedative antihistamines
ES2258175T3 (es) 2001-12-05 2006-08-16 Alcon, Inc. Utilizacion de un antagonista de h1 y remixolona como esteroide inofensivo para el tratamiento de la rinitis.
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20040019882A1 (en) 2002-07-26 2004-01-29 Haydt Robert J. Scalable data communication model
RU2220740C1 (ru) 2002-08-30 2004-01-10 Гапонюк Петр Яковлевич Средство для лечения аллергического ринита и аллергического конъюнктивита
JP2004168709A (ja) 2002-11-20 2004-06-17 Nidek Co Ltd 抗アレルギー点眼点鼻用組成物
WO2004069157A2 (en) 2003-01-17 2004-08-19 Ophthalmic Research Associates, Inc. Combinational use of long-acting and short-acting anti-histamines for ocular allergies
US20050090527A1 (en) 2003-01-28 2005-04-28 Schering Corporation Combination of H1, H3 and H4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US20040198743A1 (en) 2003-01-31 2004-10-07 Schering Corporation Methods for treating allergic skin and allergic ocular conditions using combinations of histamine receptor antagonists
US20050023974A1 (en) 2003-08-01 2005-02-03 Universal Display Corporation Protected organic electronic devices and methods for making the same
US20070027597A1 (en) 2003-09-23 2007-02-01 Daimlerchrysler Ag Method and device for recognising lane changing operations for a motor vehicle
WO2005030331A1 (en) 2003-09-26 2005-04-07 Fairfield Clinical Trials, Llc Combination antihistamine medication
US20060263350A1 (en) 2003-09-26 2006-11-23 Fairfield Clinical Trials Llc Combination antihistamine medication
US20050239745A1 (en) 2004-03-03 2005-10-27 Ophthalmic Research Associates, Inc. Novel topical ophthalmic formulations
US20050255154A1 (en) 2004-05-11 2005-11-17 Lena Pereswetoff-Morath Method and composition for treating rhinitis
US8372814B2 (en) 2004-06-07 2013-02-12 Ista Pharmaceuticals, Inc. Ophthalmic formulations and uses thereof
PE20060484A1 (es) 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
JP3897777B2 (ja) 2004-07-23 2007-03-28 株式会社半導体理工学研究センター パルスベース通信システム
WO2006010294A1 (en) 2004-07-26 2006-02-02 Quanta Display Inc. Liquid crystal display device
US7337789B2 (en) 2004-07-27 2008-03-04 Minel Kupferberg Cleaning apparatus for exhaust system and method
US7307535B2 (en) 2004-07-27 2007-12-11 Datamars S.A. Air coil RF transponder and method of making same
WO2006010255A2 (en) 2004-07-30 2006-02-02 Research In Motion Limited Method and apparatus for provisioning a communications client on a host device
US20070020330A1 (en) * 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
WO2006102494A2 (en) 2005-03-23 2006-09-28 Elan Pharma International Limited Nanoparticulate corticosteroid and antihistamine formulations
JP2007012937A (ja) 2005-06-30 2007-01-18 Seiko Epson Corp 表示ドライバ
BRPI0615032A2 (pt) * 2005-09-01 2011-04-26 Biolipox Ab composição farmacêutica, processo para a preparação da mesma, e, uso de uma composição
JP5292277B2 (ja) 2006-03-31 2013-09-18 ビスタコン・フアーマシユーチカルズ・エルエルシー 眼アレルギーの処置
US20080008592A1 (en) 2006-06-27 2008-01-10 Societe De Commercialisation Des Produits De La Recherche Appliquee - Socpra-Sc Method and apparatus for controlling tonal noise from subsonic axial fans
KR100834625B1 (ko) 2006-07-27 2008-06-02 삼성전자주식회사 비디오 인코딩 데이터율 제어를 위한 실시간 장면 전환검출 방법
BRPI0718374A2 (pt) 2006-09-29 2013-06-25 Johnson & Johnson Vision Care mÉtodos e dispositivos oftÁlmicos usados no tratamento de alergias oculares
RU2009141592A (ru) 2007-04-11 2011-05-20 Алькон Рисерч, Лтд. (Us) ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА
CN106038481A (zh) * 2007-06-28 2016-10-26 锡德克斯药物公司 皮质类固醇水溶液的鼻部和眼部给药
CA2755679C (en) 2009-03-17 2017-09-12 Aciex Therapeutics, Inc. Ophthalmic formulations of cetirizine and methods of use

Similar Documents

Publication Publication Date Title
JP2012520882A5 (enExample)
ES2587869T3 (es) Composición oftálmica de olopatadina de concentración alta
JP6527341B2 (ja) ポビドンヨード、眼科用組成物のための新規代替保存剤
ES2635197T3 (es) Composición farmacéutica que tiene biodisponibilidad deseable
ATE428401T1 (de) Suspensionsformulierungen mit einem aktiven wirkstoff, einem poloxamer- oder meroxapol-tensid und einem glycol und ihre verwendung zur herstellung eines medikaments zur behandlung von augenkrankheiten
WO2010107525A1 (en) Ophthalmic formulations of ketotifen and methods of use
BR112015029512A8 (pt) derivados de pirazolopirrolidina, seus usos, e composição e combinação farmacêuticas
BR112015029491A2 (pt) derivados de imidazopirrolidinona e seu uso no tratamento de doença
TWI832920B (zh) 抑制軟性隱形眼鏡變質之眼科用組成物
IL314873A (en) Compositions and methods for treating disorders ameliorated by muscarnic receptor activation
US9161923B2 (en) Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease
JP2010514798A (ja) 面状両親媒性ポリマー及びオリゴマーの眼科用及び耳科用組成物とその使用
BR112015029401A8 (pt) derivados de pirazolo-pirrolidin-4-ona, seus usos, e composição e combinação farmacêuticas
MX2011009802A (es) Formulaciones oftalmicas de cetirizina y metodos de uso.
RU2013150861A (ru) Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний
JP2016516074A5 (enExample)
JP2013500977A5 (enExample)
WO2018234871A3 (en) COMPOSITIONS FOR DRUG DELIVERY AND METHODS OF USE
JP2024116303A (ja) 点眼剤
JP2018508545A (ja) ブリモニジン及びチモロールの固定用量合剤
SA520412443B1 (ar) تركيبات للعين تُعطى مرة يوميًا من مركبات بنزيميدازول
AU2017261303A1 (en) Ophthalmic compositions
AR085273A1 (es) Formulacion liquida libre de propelente que comprende una droga antimuscarinica
JP6449774B2 (ja) 両性イオン性ソフトコンタクトレンズ用眼科用組成物
RU2016103098A (ru) Способ предотвращения и/или лечения хронической травматической энцефалопатии - ii